Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1411 to 1425 of 1596 results for nice quality standards or clinical guidelines

  1. Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs (TA445)

    Evidence-based recommendations on certolizumab pegol (Cimzia) and secukinumab (Cosentyx) for treating active psoriatic arthritis in adults.

  2. The impact of Sherlock 3CG tip location and confirmation system (TCS) for PICC placement in our Radiology-based vascular access service.

    of staff shortages we had to review the service. Following publication of NICE MTG 24 in 2015 we undertook a successful evaluation of...

  3. Sonata system for diagnostic imaging and treatment of symptomatic uterine fibroids (MIB255)

    NICE has developed a medtech innovation briefing (MIB) on the Sonata system for diagnostic imaging and treatment of symptomatic uterine fibroids .

  4. Adopting Peristeen and other transanal irrigation systems for people with functional bowel disorders

    problems in line with relevant guidance including the NICE faecal incontinence in adult's guideline. The team expanded the...

  5. Delivering Rehabilitation EnAblement in CHronic Heart Failure (REACH-HF) in Wirral

    option for patients with heart failure and is covered by multiple NICE guidelines and Quality statements...

  6. Re-engineering the Post-Myocardial Infarction Medicines Optimisation Pathway

    Despite multiple NICE published guidance, quality standards, and technology appraisals, to reduce the burden...

  7. Cannabidiol with clobazam for treating seizures associated with Dravet syndrome (TA614)

    Evidence-based recommendations on cannabidiol (Epidyolex) with clobazam for seizures associated with Dravet syndrome in people aged 2 years and older.

  8. Diagnostic technologies stakeholder registration

    who is one of the following: The company that notified the technology to NICE, and sponsors or manufacturers of related technologies. A...

  9. Developing and communicating effective pathways for patients with sarcoma in London and South East England

    created to publish and increase awareness of the pathways and supporting guidelines, including information on site-specific sarcomas....

  10. Sorafenib for treating advanced hepatocellular carcinoma (TA474)

    Evidence-based recommendations on sorafenib (Nexavar) for treating advanced hepatocellular carcinoma in adults.

  11. What is the clinical and cost effectiveness of cannabis-based medicinal products other than THC: CBD spray for children, young people and adults with spasticity? In particular, what is the impact of spasticity on improvements in quality of life?

    Recommendation ID NG144/5 Question What is the clinical and cost effectiveness of cannabis-based medicinal products other than THC: CBD

  12. Symptomatic Breast Referral Resource Suite: Enhancing the Suspected Cancer Recognition and Referral Process

    to other NICE resources including Patient experience in adult NHS services overview , Patient Experience in Adult NHS Services CG138 ,...

  13. Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years (TA213)

    Evidence-based recommendations on aripiprazole for treating schizophrenia in young people aged 15 to 17.

  14. Urinary incontinence and pelvic organ prolapse in women. Patient decision aid on surgery for vaginal vault prolapse

    Surgery for vaginal vault prolapse Patient decision aid ? 1 c NICE 2019. All rights reserved. Subject to Notice of rights. Last updated...

  15. Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19 (TA878)

    Evidence-based recommendations on nirmatrelvir plus ritonavir (Paxlovid), sotrovimab (Xevudy) and tocilizumab (RoActemra) for treating COVID-19.